Pall launches new leukocyte reduction filter

Pall Corp. has released a new dual disc design (RC2H) leukocyte reduction filter designed to be used with the Haemonetics automated double red cell collection system.

The filter technology, coupled with the double red cell automated collection system, will help blood centers increase the availability of blood in their communities while bringing the added safety of leukocyte reduction to the blood supply. The FDA recently cleared the new collection system for market.

The blood collection system uses a process called apheresis with an application that doubles the amount of red blood cells collected from a single donor. The dual disc filter in the system reduces the potentially harmful white blood cells, the primary cause of adverse transfusion reactions.

According to the company, the filter offers enhanced flow and increased surface area over currently used filters. This design will further optimize levels of filtration performance to the blood bank by decreasing filtration times when the double red cell collection system is used, as well as assure performance consistency and flow with the variable properties of the blood that is filtered.

For more information, visit the company's storefront on Medical Design Online.

Edited by Ursula Jones
Managing Editor, Medical Design Online